Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Still no takers

<< Previous

Bullboard Posts

Next >>

Comment by Dumbeldorfwhiteon Nov 28, 2024 6:44am

73 Views

Post# 36335104

RE:RE:RE:RE:RE:RE:RE:RE:RE:Still no takers

That's because you are reading into the "manipulated numbers" it's not 43.6% CR at 450 days it's 26% (17/63) . TLT is presenting their numbers now as a percent of a percent. Of the 38 complete responders 17 maintained that CR (43% ) but in actuality only 17/63 were CR at 450.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing